One of the causes of thyroid dysfunction in DM and MS may be the weakening of insulin signaling in the brain and the disruption of the interaction between the hypothalamic insulin and leptin pathways, which are synergistic to stimulate TRH production. This evidence concerns the gene TRH and myeloid sarcoma.